首页 > 最新文献

Heart International最新文献

英文 中文
Complications with Left Bundle Branch Area Pacing: The Flip Side of the Coin. 左束分支区域起搏的并发症:硬币的反面。
IF 2.3 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-06-19 eCollection Date: 2025-01-01 DOI: 10.17925/HI.2025.19.1.3
Samuel Stempfel, Heli Tolppanen, Valérian Valiton, Haran Burri

Left bundle branch area pacing has been a breakthrough in pacing therapy and is being increasingly adopted. It delivers a more physiological form of pacing compared with right ventricular and biventricular pacing and also avoids the risk of perforation of the ventricular free wall. However, the therapy comes at the price of new complications related to the transseptal route for placing the lead. This article provides an update on these complications and discusses how to avoid and manage these adverse events.

左束支区起搏已成为起搏治疗的一个突破,并越来越多地被采用。与右心室和双心室起搏相比,它提供了一种更生理的起搏形式,也避免了心室游离壁穿孔的风险。然而,该疗法的代价是与放置导线的跨隔膜路径相关的新并发症。本文提供了这些并发症的最新进展,并讨论了如何避免和处理这些不良事件。
{"title":"Complications with Left Bundle Branch Area Pacing: The Flip Side of the Coin.","authors":"Samuel Stempfel, Heli Tolppanen, Valérian Valiton, Haran Burri","doi":"10.17925/HI.2025.19.1.3","DOIUrl":"10.17925/HI.2025.19.1.3","url":null,"abstract":"<p><p>Left bundle branch area pacing has been a breakthrough in pacing therapy and is being increasingly adopted. It delivers a more physiological form of pacing compared with right ventricular and biventricular pacing and also avoids the risk of perforation of the ventricular free wall. However, the therapy comes at the price of new complications related to the transseptal route for placing the lead. This article provides an update on these complications and discusses how to avoid and manage these adverse events.</p>","PeriodicalId":12836,"journal":{"name":"Heart International","volume":"19 1","pages":"26-30"},"PeriodicalIF":2.3,"publicationDate":"2025-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12285660/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144707266","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retrospective Comparison of Device Versus Suture for Patent Foramen Ovale Closure. 器械与缝合治疗卵圆孔未闭的回顾性比较。
IF 2.3 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-06-19 eCollection Date: 2025-01-01 DOI: 10.17925/HI.2025.19.1.4
Bryan W Kluck, Rahul Gupta, Andrew Orzel

Background: The use of an implantable closure device with medical therapy to prevent recurrent stroke in patent foramen ovale (PFO)-associated stroke has been shown to be superior to medical therapy alone. Recently, an alternative, suture-based method also has shown promise for effective PFO closure. There has been little published data comparing the outcomes of these two technologies.

Methods: This retrospective study explores the safety and efficacy outcomes of device-based versus suture-based percutaneous PFO intervention. The occurrence of post-procedural atrial fibrillation was of primary interest. Data from 55 single-institution, single-operator PFO closure cases between 1 January 2021 and 8 April 2022 were analyzed. Closure occurred via one of two Food and Drug Administration (FDA)-approved occluders or the NobleStitch™ EL suture-based approach. Data were transcribed into a registered REDCap database for descriptive analysis. Demographics, medical history, imaging, procedural and post-procedural outcomes were the variables collected for each participant.

Results: All patients had successful PFO closure without major adverse outcomes. Overall efficacy was similar between the two groups. No patient had a residual shunt greater than grade 1. Several suture-group patients required multiple sutures for satisfactory closure. Those who had multiple sutures had no anomalous anatomic PFO features. Three patients (5%), all from the device group, developed atrial fibrillation after PFO closure.

Conclusions: This study supports the safety and efficacy of device- and suture-based approaches in PFO closure. Suture-based closure would seem a reasonable option where device-based closure raises concerns. Future studies could further explore the observed disparity of atrial fibrillation occurrence between the two PFO closure strategies.

背景:使用植入式闭合装置联合药物治疗预防卵圆孔未闭(PFO)相关卒中复发已被证明优于单独药物治疗。最近,另一种基于缝线的方法也显示出有效闭合PFO的希望。很少有公开的数据比较这两种技术的结果。方法:本回顾性研究探讨了基于器械与基于缝线的经皮PFO介入治疗的安全性和有效性。术后房颤的发生是主要关注的问题。分析了2021年1月1日至2022年4月8日期间55例单一机构、单一运营商PFO关闭病例的数据。通过美国食品和药物管理局(FDA)批准的两种封堵器之一或基于NobleStitch™EL缝合的方法进行闭合。将数据转录到注册的REDCap数据库中进行描述性分析。统计数据、病史、影像学、手术和手术后结果是为每个参与者收集的变量。结果:所有患者均成功关闭PFO,无主要不良后果。两组的总体疗效相似。没有患者的残余分流大于1级。几例缝合组患者需要多次缝合才能达到满意的缝合效果。那些有多个缝合线的患者没有异常的PFO解剖特征。三名患者(5%)均来自器械组,在PFO闭合后发生房颤。结论:本研究支持基于器械和基于缝线的入路在PFO闭合中的安全性和有效性。在基于设备的关闭引起关注的情况下,基于缝线的关闭似乎是一个合理的选择。未来的研究可以进一步探讨两种PFO关闭策略间房颤发生率的差异。
{"title":"Retrospective Comparison of Device Versus Suture for Patent Foramen Ovale Closure.","authors":"Bryan W Kluck, Rahul Gupta, Andrew Orzel","doi":"10.17925/HI.2025.19.1.4","DOIUrl":"10.17925/HI.2025.19.1.4","url":null,"abstract":"<p><strong>Background: </strong>The use of an implantable closure device with medical therapy to prevent recurrent stroke in patent foramen ovale (PFO)-associated stroke has been shown to be superior to medical therapy alone. Recently, an alternative, suture-based method also has shown promise for effective PFO closure. There has been little published data comparing the outcomes of these two technologies.</p><p><strong>Methods: </strong>This retrospective study explores the safety and efficacy outcomes of device-based versus suture-based percutaneous PFO intervention. The occurrence of post-procedural atrial fibrillation was of primary interest. Data from 55 single-institution, single-operator PFO closure cases between 1 January 2021 and 8 April 2022 were analyzed. Closure occurred via one of two Food and Drug Administration (FDA)-approved occluders or the NobleStitch™ EL suture-based approach. Data were transcribed into a registered REDCap database for descriptive analysis. Demographics, medical history, imaging, procedural and post-procedural outcomes were the variables collected for each participant.</p><p><strong>Results: </strong>All patients had successful PFO closure without major adverse outcomes. Overall efficacy was similar between the two groups. No patient had a residual shunt greater than grade 1. Several suture-group patients required multiple sutures for satisfactory closure. Those who had multiple sutures had no anomalous anatomic PFO features. Three patients (5%), all from the device group, developed atrial fibrillation after PFO closure.</p><p><strong>Conclusions: </strong>This study supports the safety and efficacy of device- and suture-based approaches in PFO closure. Suture-based closure would seem a reasonable option where device-based closure raises concerns. Future studies could further explore the observed disparity of atrial fibrillation occurrence between the two PFO closure strategies.</p>","PeriodicalId":12836,"journal":{"name":"Heart International","volume":"19 1","pages":"48-56"},"PeriodicalIF":2.3,"publicationDate":"2025-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12285659/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144707270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multidimensional Determinants of Functional Status in Patients with Heart Failure. 心力衰竭患者功能状态的多维决定因素。
IF 2.3 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-05-21 eCollection Date: 2025-01-01 DOI: 10.17925/HI.2025.19.1.2
Jia-Rong Wu, Abigail Latimer, Ashmita Thapa, Cynthia Arslanian-Engoren, Jennifer L Smith, Jessica Harman Thompson, Chin-Yen Lin, JungHee Kang, Muna Hammash, Muhammad I Amin, Martha J Biddle, Kyoung Suk Lee, Seongkum Heo, Debra K Moser

Introduction: Functional status is a predictor of rehospitalization and mortality in patients with heart failure (HF). The purpose of this study was to test the variables in the Multidimensional Model of Functional Status (MMFS) as determinants of functional status.

Methods: Using structural equation modelling, we analysed data from 520 patients with HF to determine the best multivariate model of functional status. In the MMFS, the potential determinants of functional status include demographic, clinical, psychosocial, behavioural and symptom burden variables. We measured functional status using the Duke Activity Status Index. Other variables were collected by standardized questionnaires and patient interviews.

Results: Patients who were older, less educated, or had greater comorbidity burden or greater symptom burden had worse functional status. Sex, body mass index, depression, anxiety and social support were indirectly associated with functional status mediated by symptom burden. Being married was indirectly associated with better functional status via the pathways of more social support and fewer depressive symptoms through lower symptom burden.

Conclusion: Multidimensional variables proposed in the MMFS were directly and indirectly associated with functional status. Among these variables, symptom burden is the most important mediator. Targeting these variables, especially symptom burden, may improve patients' functional status.

功能状态是心衰(HF)患者再住院和死亡率的预测因子。本研究的目的是测试功能状态多维模型(MMFS)中的变量作为功能状态的决定因素。方法:采用结构方程模型,分析520例心衰患者的数据,以确定功能状态的最佳多变量模型。在MMFS中,功能状态的潜在决定因素包括人口统计学、临床、社会心理、行为和症状负担变量。我们使用杜克活动状态指数来测量功能状态。其他变量通过标准化问卷和患者访谈收集。结果:年龄较大、受教育程度较低、合并症负担或症状负担较重的患者功能状况较差。性别、体重指数、抑郁、焦虑和社会支持间接影响症状负担介导的功能状态。婚姻通过更多的社会支持和更少的抑郁症状通过更低的症状负担间接与更好的功能状态相关。结论:MMFS中提出的多维变量与功能状态直接或间接相关。在这些变量中,症状负担是最重要的中介变量。针对这些变量,特别是症状负担,可能会改善患者的功能状态。
{"title":"Multidimensional Determinants of Functional Status in Patients with Heart Failure.","authors":"Jia-Rong Wu, Abigail Latimer, Ashmita Thapa, Cynthia Arslanian-Engoren, Jennifer L Smith, Jessica Harman Thompson, Chin-Yen Lin, JungHee Kang, Muna Hammash, Muhammad I Amin, Martha J Biddle, Kyoung Suk Lee, Seongkum Heo, Debra K Moser","doi":"10.17925/HI.2025.19.1.2","DOIUrl":"10.17925/HI.2025.19.1.2","url":null,"abstract":"<p><strong>Introduction: </strong>Functional status is a predictor of rehospitalization and mortality in patients with heart failure (HF). The purpose of this study was to test the variables in the Multidimensional Model of Functional Status (MMFS) as determinants of functional status.</p><p><strong>Methods: </strong>Using structural equation modelling, we analysed data from 520 patients with HF to determine the best multivariate model of functional status. In the MMFS, the potential determinants of functional status include demographic, clinical, psychosocial, behavioural and symptom burden variables. We measured functional status using the Duke Activity Status Index. Other variables were collected by standardized questionnaires and patient interviews.</p><p><strong>Results: </strong>Patients who were older, less educated, or had greater comorbidity burden or greater symptom burden had worse functional status. Sex, body mass index, depression, anxiety and social support were indirectly associated with functional status mediated by symptom burden. Being married was indirectly associated with better functional status via the pathways of more social support and fewer depressive symptoms through lower symptom burden.</p><p><strong>Conclusion: </strong>Multidimensional variables proposed in the MMFS were directly and indirectly associated with functional status. Among these variables, symptom burden is the most important mediator. Targeting these variables, especially symptom burden, may improve patients' functional status.</p>","PeriodicalId":12836,"journal":{"name":"Heart International","volume":"19 1","pages":"41-47"},"PeriodicalIF":2.3,"publicationDate":"2025-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12285664/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144707269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Community-based Participatory Research in Cardiovascular Disease Prevention for Middle-aged Women: A Systematic Review. 以社区为基础的中年妇女心血管疾病预防参与性研究:系统综述
IF 2.3 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-04-11 eCollection Date: 2025-01-01 DOI: 10.17925/HI.2025.19.1.1
Rnda I Ashgar

Background: Cardiovascular disease (CVD) remains a leading cause of morbidity and mortality among women, particularly those of childbearing age and middle-aged women, who face heightened risks due to physiological changes, stress and systemic barriers. Women of colour and those from low socioeconomic backgrounds are disproportionately affected.

Aim: This article evaluates the effectiveness of community-based participatory research (CBPR) in reducing CVD risk among midlife women, emphasizing the cultural relevance of interventions as a critical factor for success.

Methodology: Following the PRISMA guidelines, a systematic search of PubMed, Scopus and Web of Science identified 15 studies, including randomized controlled trials, practice-based participatory research (PBPRs) and mixed-methods research. These studies implemented CBPR interventions focusing on diet, physical activity, stress management and community participation for underserved populations. Outcomes measured included systolic and diastolic blood pressure, serum cholesterol, Body Mass Index (BMI) and fasting blood glucose, as well as participants' knowledge, behaviours and perceived community capacity.

Results: The analysis showed reductions in systolic and diastolic blood pressure (7 and 4 mmHg, respectively), low-density lipoprotein cholesterol (10-15 mg/dL) and BMI (0.5-1.2 kg/m²), along with increases in high-density lipoprotein cholesterol (5-8 mg/dL). Culturally tailored interventions, such as dietary adjustments, group exercise and peer support, demonstrated improved compliance and maintenance of behavioural changes. Patterns of cultural relevance, trust and community ownership emerged as key determinants of success. CBPR offers significant potential for addressing health disparities and reducing CVD risk.

Conclusion: Expanding CBPR approaches and conducting long-term interventions can enhance health equity and achieve lasting benefits across diverse populations.

背景:心血管疾病(CVD)仍然是妇女发病和死亡的主要原因,特别是育龄妇女和中年妇女,她们由于生理变化、压力和全身障碍而面临更高的风险。有色人种女性和社会经济背景较低的女性受到的影响尤为严重。目的:本文评估基于社区的参与式研究(CBPR)在降低中年妇女心血管疾病风险方面的有效性,强调干预措施的文化相关性是成功的关键因素。方法:遵循PRISMA指南,系统搜索PubMed, Scopus和Web of Science确定了15项研究,包括随机对照试验,基于实践的参与性研究(PBPRs)和混合方法研究。这些研究实施了CBPR干预措施,重点关注服务不足人群的饮食、身体活动、压力管理和社区参与。测量的结果包括收缩压和舒张压、血清胆固醇、身体质量指数(BMI)和空腹血糖,以及参与者的知识、行为和感知的社区能力。结果:分析显示收缩压和舒张压(分别为7和4 mmHg),低密度脂蛋白胆固醇(10-15 mg/dL)和BMI (0.5-1.2 kg/m²)降低,高密度脂蛋白胆固醇(5-8 mg/dL)增加。适应文化的干预措施,如饮食调整、团体锻炼和同伴支持,显示出行为改变的依从性和维持性得到改善。文化关联、信任和社区所有权的模式成为成功的关键决定因素。CBPR为解决健康差距和降低心血管疾病风险提供了巨大潜力。结论:扩大CBPR方法和开展长期干预措施可以增强卫生公平,并在不同人群中实现持久效益。
{"title":"Community-based Participatory Research in Cardiovascular Disease Prevention for Middle-aged Women: A Systematic Review.","authors":"Rnda I Ashgar","doi":"10.17925/HI.2025.19.1.1","DOIUrl":"10.17925/HI.2025.19.1.1","url":null,"abstract":"<p><strong>Background: </strong>Cardiovascular disease (CVD) remains a leading cause of morbidity and mortality among women, particularly those of childbearing age and middle-aged women, who face heightened risks due to physiological changes, stress and systemic barriers. Women of colour and those from low socioeconomic backgrounds are disproportionately affected.</p><p><strong>Aim: </strong>This article evaluates the effectiveness of community-based participatory research (CBPR) in reducing CVD risk among midlife women, emphasizing the cultural relevance of interventions as a critical factor for success.</p><p><strong>Methodology: </strong>Following the PRISMA guidelines, a systematic search of PubMed, Scopus and Web of Science identified 15 studies, including randomized controlled trials, practice-based participatory research (PBPRs) and mixed-methods research. These studies implemented CBPR interventions focusing on diet, physical activity, stress management and community participation for underserved populations. Outcomes measured included systolic and diastolic blood pressure, serum cholesterol, Body Mass Index (BMI) and fasting blood glucose, as well as participants' knowledge, behaviours and perceived community capacity.</p><p><strong>Results: </strong>The analysis showed reductions in systolic and diastolic blood pressure (7 and 4 mmHg, respectively), low-density lipoprotein cholesterol (10-15 mg/dL) and BMI (0.5-1.2 kg/m²), along with increases in high-density lipoprotein cholesterol (5-8 mg/dL). Culturally tailored interventions, such as dietary adjustments, group exercise and peer support, demonstrated improved compliance and maintenance of behavioural changes. Patterns of cultural relevance, trust and community ownership emerged as key determinants of success. CBPR offers significant potential for addressing health disparities and reducing CVD risk.</p><p><strong>Conclusion: </strong>Expanding CBPR approaches and conducting long-term interventions can enhance health equity and achieve lasting benefits across diverse populations.</p>","PeriodicalId":12836,"journal":{"name":"Heart International","volume":"19 1","pages":"12-19"},"PeriodicalIF":2.3,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12285662/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144707265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Coronary Dissection - Back to the Future - Finding Good in the Bad! 冠状动脉解剖-回到未来-在坏中发现好的!
IF 1.9 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-12-18 eCollection Date: 2024-01-01 DOI: 10.17925/HI.2024.18.2.5
Rajkumar Natarajan, Natasha Corballis, Ioannis Merinopoulos, Vassilios S Vassiliou, Simon C Eccleshall

It has been recognized for decades that dissections occur as a mechanism of balloon angioplasty. A successful angioplasty result contains some degree of intimal splitting and disruption, which usually heals well. Nonetheless, some dissections are extensive, leading to serious ischaemic complications. The concept of therapeutic coronary dissection started evolving in the 1970s and seems to be a favourable mechanism for drug delivery in the current era of drug-coated balloons. This article will primarily focus on studies undertaken to understand the mechanism of balloon angioplasty and the morphological changes in the plaque post-balloon angioplasty. In the early days of balloon angioplasty, there was an enormous interest in dissections, mainly to prevent acute vessel closure events and to address the importance of their occurrence in relation to vessel restenosis. We will review the historical background, studies defining the clinical, angiographic and morphological patterns of the dissection spectrum and various currently evolving management strategies.

几十年来,人们已经认识到解剖是球囊血管成形术的一种机制。成功的血管成形术包含一定程度的内膜分裂和破裂,通常愈合良好。尽管如此,一些剥离是广泛的,导致严重的缺血性并发症。治疗性冠状动脉解剖的概念始于20世纪70年代,在当前的药物涂层气球时代,这似乎是一种有利的药物输送机制。本文将主要关注球囊血管成形术的机制和球囊血管成形术后斑块的形态学变化。在球囊血管成形术的早期,人们对解剖非常感兴趣,主要是为了防止急性血管关闭事件,并解决其发生与血管再狭窄相关的重要性。我们将回顾历史背景,研究定义临床,血管造影和解剖谱的形态模式和各种目前发展的管理策略。
{"title":"Coronary Dissection - Back to the Future - Finding Good in the Bad!","authors":"Rajkumar Natarajan, Natasha Corballis, Ioannis Merinopoulos, Vassilios S Vassiliou, Simon C Eccleshall","doi":"10.17925/HI.2024.18.2.5","DOIUrl":"10.17925/HI.2024.18.2.5","url":null,"abstract":"<p><p>It has been recognized for decades that dissections occur as a mechanism of balloon angioplasty. A successful angioplasty result contains some degree of intimal splitting and disruption, which usually heals well. Nonetheless, some dissections are extensive, leading to serious ischaemic complications. The concept of therapeutic coronary dissection started evolving in the 1970s and seems to be a favourable mechanism for drug delivery in the current era of drug-coated balloons. This article will primarily focus on studies undertaken to understand the mechanism of balloon angioplasty and the morphological changes in the plaque post-balloon angioplasty. In the early days of balloon angioplasty, there was an enormous interest in dissections, mainly to prevent acute vessel closure events and to address the importance of their occurrence in relation to vessel restenosis. We will review the historical background, studies defining the clinical, angiographic and morphological patterns of the dissection spectrum and various currently evolving management strategies.</p>","PeriodicalId":12836,"journal":{"name":"Heart International","volume":"18 2","pages":"14-23"},"PeriodicalIF":1.9,"publicationDate":"2024-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11781370/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143065142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transcatheter Management of Tricuspid Regurgitation: A Review of Contemporary Evidence. 经导管治疗三尖瓣反流:当代证据综述。
IF 1.9 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-12-18 eCollection Date: 2024-01-01 DOI: 10.17925/HI.2024.18.2.4
Yasser M Sammour, Muhammad Faraz Anwaar, Francisco Cabral-Amador, Jian Garcia, Joe Aoun, Sana Kazmi, Nadeen Faza, Stephen H Little, Michael J Reardon, Neal S Kleiman, Sachin S Goel

Tricuspid regurgitation (TR) is a common valvular heart disease that is associated with increased morbidity and mortality. Traditional surgical interventions, though definitive, carry considerable complexities and risks, especially for high-risk patients, with in-hospital mortality rates of ˜9%. This resulted in the undertreatment of many patients with TR, creating a substantial unmet need. This has stimulated the development of transcatheter techniques, such as transcatheter tricuspid valve replacement, tricuspid edge-to-edge repair, tricuspid annuloplasty, caval valve implantation and many others, which offer less-i nvasive alternatives with promising early results and sustained benefits. This review provides a contemporary outlook on different transcatheter tricuspid valve interventions in patients with severe TR and assesses the existing clinical data regarding the safety and effectiveness of these devices in a rapidly expanding space.

三尖瓣反流(TR)是一种常见的瓣膜性心脏病,与发病率和死亡率增高有关。传统的手术干预虽然具有决定性,但具有相当大的复杂性和风险,特别是对于高危患者,住院死亡率约为9%。这导致许多TR患者治疗不足,造成大量未满足的需求。这刺激了经导管技术的发展,如经导管三尖瓣置换术、三尖瓣边缘到边缘修复术、三尖瓣环成形术、腔静脉瓣膜植入术等,这些技术提供了侵入性较小的替代方法,具有良好的早期效果和持续的益处。这篇综述提供了不同的经导管三尖瓣介入治疗严重TR患者的当代前景,并评估了这些装置在快速扩大的空间中安全性和有效性的现有临床数据。
{"title":"Transcatheter Management of Tricuspid Regurgitation: A Review of Contemporary Evidence.","authors":"Yasser M Sammour, Muhammad Faraz Anwaar, Francisco Cabral-Amador, Jian Garcia, Joe Aoun, Sana Kazmi, Nadeen Faza, Stephen H Little, Michael J Reardon, Neal S Kleiman, Sachin S Goel","doi":"10.17925/HI.2024.18.2.4","DOIUrl":"10.17925/HI.2024.18.2.4","url":null,"abstract":"<p><p>Tricuspid regurgitation (TR) is a common valvular heart disease that is associated with increased morbidity and mortality. Traditional surgical interventions, though definitive, carry considerable complexities and risks, especially for high-risk patients, with in-hospital mortality rates of ˜9%. This resulted in the undertreatment of many patients with TR, creating a substantial unmet need. This has stimulated the development of transcatheter techniques, such as transcatheter tricuspid valve replacement, tricuspid edge-to-edge repair, tricuspid annuloplasty, caval valve implantation and many others, which offer less-i nvasive alternatives with promising early results and sustained benefits. This review provides a contemporary outlook on different transcatheter tricuspid valve interventions in patients with severe TR and assesses the existing clinical data regarding the safety and effectiveness of these devices in a rapidly expanding space.</p>","PeriodicalId":12836,"journal":{"name":"Heart International","volume":"18 2","pages":"24-36"},"PeriodicalIF":1.9,"publicationDate":"2024-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11781372/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143065150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Understanding Diabetic Cardiomyopathy: Insulin Resistance and Beyond. 了解糖尿病性心肌病:胰岛素抵抗及其他。
IF 1.9 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-12-04 eCollection Date: 2024-01-01 DOI: 10.17925/HI.2024.18.2.2
Aditya John Binu, Nitin Kapoor

Background: Diabetic cardiomyopathy (DC) is a syndrome of heart failure occurring in patients with diabetes mellitus (DM), independent of other risk factors. It is a relatively underdiagnosed condition with a prolonged subclinical phase. There is an abundance of studies put forward to explain the underlying pathogenic mechanisms observed in this condition. This review aims to summarize the evidence available in contemporary medical literature with regard to the molecular mechanisms, abnormalities in signalling and metabolism and structural and functional abnormalities manifesting as DC. Methods: We conducted a literature search using the terms 'diabetic cardiomyopathy', 'heart failure AND Diabetes mellitus', 'Cardiomyopathy AND Diabetes mellitus'. We searched the reference lists of included studies and relevant systematic reviews. Results: In this review, we elucidate all the mechanisms that have been postulated to have a role in the pathogenesis of DC, in addition to insulin resistance, such as inflammation, renin-angiotensin-aldosterone system activation and deranged protein homeostasis. Conclusions: DC is an underrecognized cardiac complication of DM. A comprehensive knowledge of all the pathways and mediators will aid in the development of diagnostic and prognostic markers, screening protocols and novel management strategies.

背景:糖尿病性心肌病(DC)是发生在糖尿病(DM)患者的心力衰竭综合征,独立于其他危险因素。这是一种诊断相对较低的疾病,具有较长的亚临床期。有大量的研究提出来解释在这种情况下观察到的潜在致病机制。本文旨在总结当代医学文献中有关DC的分子机制、信号和代谢异常以及结构和功能异常的证据。方法:我们使用“糖尿病性心肌病”、“心力衰竭和糖尿病”、“心肌病和糖尿病”等术语进行文献检索。我们检索了纳入研究的参考文献和相关的系统综述。结果:在这篇综述中,我们阐明了除胰岛素抵抗外,所有被认为在DC发病机制中起作用的机制,如炎症、肾素-血管紧张素-醛固酮系统激活和蛋白质稳态紊乱。结论:DC是糖尿病的一种未被充分认识的心脏并发症。全面了解所有通路和介质将有助于开发诊断和预后标志物、筛查方案和新的管理策略。
{"title":"Understanding Diabetic Cardiomyopathy: Insulin Resistance and Beyond.","authors":"Aditya John Binu, Nitin Kapoor","doi":"10.17925/HI.2024.18.2.2","DOIUrl":"10.17925/HI.2024.18.2.2","url":null,"abstract":"<p><p><b>Background:</b> Diabetic cardiomyopathy (DC) is a syndrome of heart failure occurring in patients with diabetes mellitus (DM), independent of other risk factors. It is a relatively underdiagnosed condition with a prolonged subclinical phase. There is an abundance of studies put forward to explain the underlying pathogenic mechanisms observed in this condition. This review aims to summarize the evidence available in contemporary medical literature with regard to the molecular mechanisms, abnormalities in signalling and metabolism and structural and functional abnormalities manifesting as DC. <b>Methods:</b> We conducted a literature search using the terms 'diabetic cardiomyopathy', 'heart failure AND Diabetes mellitus', 'Cardiomyopathy AND Diabetes mellitus'. We searched the reference lists of included studies and relevant systematic reviews. <b>Results:</b> In this review, we elucidate all the mechanisms that have been postulated to have a role in the pathogenesis of DC, in addition to insulin resistance, such as inflammation, renin-angiotensin-aldosterone system activation and deranged protein homeostasis. <b>Conclusions:</b> DC is an underrecognized cardiac complication of DM. A comprehensive knowledge of all the pathways and mediators will aid in the development of diagnostic and prognostic markers, screening protocols and novel management strategies.</p>","PeriodicalId":12836,"journal":{"name":"Heart International","volume":"18 2","pages":"7-13"},"PeriodicalIF":1.9,"publicationDate":"2024-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11781369/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143065163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advancements in Leadless Pacemakers: What the Second-generation Micra AV2 Brings to Cardiac Care. 无铅起搏器的进步:第二代Micra AV2为心脏护理带来什么。
IF 1.9 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-11-29 eCollection Date: 2024-01-01 DOI: 10.17925/HI.2024.18.2.3
Christophe Garweg, Rik Willems

Leadless pacemakers are considered one of the major technological advancements in cardiology in recent years. Many efforts are made to provide physiological atrio-ventricular (AV) pacing. With the first-generation leadless ventricular, dual, dual (VDD) pacemaker, Micra AV (Medtronic, Inc., Minneapolis, MN, USA), a high variability in AV synchrony was reported. A second generation, Micra AV2, is now available for clinical use, promising smarter and higher automatic AV synchrony. This article reviews the different improvements proposed for this new device.

无铅起搏器被认为是近年来心脏病学的主要技术进步之一。许多努力都是为了提供生理房室(AV)起搏。据报道,使用第一代无导联双心室(VDD)起搏器Micra AV (Medtronic, Inc., Minneapolis, MN, USA),室间隔同步的变异性很高。第二代,Micra AV2,现在可用于临床应用,承诺更智能和更高的自动AV同步。本文回顾了针对这种新设备提出的不同改进。
{"title":"Advancements in Leadless Pacemakers: What the Second-generation Micra AV2 Brings to Cardiac Care.","authors":"Christophe Garweg, Rik Willems","doi":"10.17925/HI.2024.18.2.3","DOIUrl":"10.17925/HI.2024.18.2.3","url":null,"abstract":"<p><p>Leadless pacemakers are considered one of the major technological advancements in cardiology in recent years. Many efforts are made to provide physiological atrio-ventricular (AV) pacing. With the first-generation leadless ventricular, dual, dual (VDD) pacemaker, Micra AV (Medtronic, Inc., Minneapolis, MN, USA), a high variability in AV synchrony was reported. A second generation, Micra AV2, is now available for clinical use, promising smarter and higher automatic AV synchrony. This article reviews the different improvements proposed for this new device.</p>","PeriodicalId":12836,"journal":{"name":"Heart International","volume":"18 2","pages":"4-6"},"PeriodicalIF":1.9,"publicationDate":"2024-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11781367/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143065111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Radial Artery Thrombosis and Associated Risk Factors in Patients Undergoing Radial Coronary Angiography. 接受桡动脉冠状动脉造影患者的桡动脉血栓形成及其相关危险因素。
IF 1.9 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-10-21 eCollection Date: 2024-01-01 DOI: 10.17925/HI.2024.18.2.1
Esra Koc Ay, Ibrahim Feyyaz Naldemir, Cem Ozde, Gulsah Akture, Seda Aytekin, Osman Kayapinar, Gürkan Karaca, Ali Kimiaei, Seyedehtina Safaei, Adnan Kaya

Background: Radial access is considered the preferred method for coronary angiography (CAG) and percutaneous coronary intervention. Radial artery thrombosis (RAT) stands out as the primary complication associated with trans-radial access. Our objective was to explore the occurrence of RAT and its associated risk factors. Method: A study encompassing 150 patients who underwent coronary interventions via radial access was conducted. Colour Doppler ultrasonography was used to assess proximal and distal radial flow rates 4-6 hours post-procedure. Patients diagnosed with RAT constituted the study group, while those without RAT were designated as controls. Results: Among the 150 patients, 20 (13.3%) developed RAT, with partial occlusions observed in 2.7% and total occlusions in 10.7%. Univariate analysis identified potential correlations between RAT and variables such as female gender, hypertension (HT), history of coronary artery disease, use of anti-thrombocyte medications, duration of compression, indication for CAG, haematocrit levels, neutrophil count, creatinine levels and estimated glomerular filtration rate. However, only HT showed a statistically significant association. Multivariate analysis confirmed HT, anti-thrombocyte drug use, duration of compression, haematocrit levels and creatinine levels as independent predictors of RAT. Conclusion: HT, anti-thrombocyte drug use, duration of compression, haematocrit levels and creatinine levels are identified as independent predictors of RAT. Standard pulse examination may not adequately detect RAT.

背景:桡动脉通路被认为是冠状动脉造影(CAG)和经皮冠状动脉介入治疗的首选方法。桡动脉血栓形成(RAT)是与经桡动脉通路相关的主要并发症。我们的目的是探讨RAT的发生及其相关的危险因素。方法:对150例经桡动脉通道行冠状动脉介入治疗的患者进行研究。术后4-6小时彩色多普勒超声评估近端和远端桡动脉血流率。诊断为RAT的患者为研究组,未诊断为RAT的患者为对照组。结果:150例患者中,有20例(13.3%)发生RAT,部分闭塞占2.7%,完全闭塞占10.7%。单因素分析确定了RAT与以下变量之间的潜在相关性:女性性别、高血压(HT)、冠状动脉疾病史、抗血小板药物使用、压迫时间、CAG适应症、红细胞压积水平、中性粒细胞计数、肌酐水平和肾小球滤过率。然而,只有HT有统计学上显著的相关性。多因素分析证实HT、抗血小板药物使用、压迫时间、红细胞压积水平和肌酐水平是RAT的独立预测因素。结论:HT、抗血小板药物使用、压迫时间、红细胞压积水平和肌酐水平是RAT的独立预测因素。标准脉搏检查可能不能充分检测RAT。
{"title":"Radial Artery Thrombosis and Associated Risk Factors in Patients Undergoing Radial Coronary Angiography.","authors":"Esra Koc Ay, Ibrahim Feyyaz Naldemir, Cem Ozde, Gulsah Akture, Seda Aytekin, Osman Kayapinar, Gürkan Karaca, Ali Kimiaei, Seyedehtina Safaei, Adnan Kaya","doi":"10.17925/HI.2024.18.2.1","DOIUrl":"10.17925/HI.2024.18.2.1","url":null,"abstract":"<p><p><b>Background:</b> Radial access is considered the preferred method for coronary angiography (CAG) and percutaneous coronary intervention. Radial artery thrombosis (RAT) stands out as the primary complication associated with trans-radial access. Our objective was to explore the occurrence of RAT and its associated risk factors. <b>Method:</b> A study encompassing 150 patients who underwent coronary interventions via radial access was conducted. Colour Doppler ultrasonography was used to assess proximal and distal radial flow rates 4-6 hours post-procedure. Patients diagnosed with RAT constituted the study group, while those without RAT were designated as controls. <b>Results:</b> Among the 150 patients, 20 (13.3%) developed RAT, with partial occlusions observed in 2.7% and total occlusions in 10.7%. Univariate analysis identified potential correlations between RAT and variables such as female gender, hypertension (HT), history of coronary artery disease, use of anti-thrombocyte medications, duration of compression, indication for CAG, haematocrit levels, neutrophil count, creatinine levels and estimated glomerular filtration rate. However, only HT showed a statistically significant association. Multivariate analysis confirmed HT, anti-thrombocyte drug use, duration of compression, haematocrit levels and creatinine levels as independent predictors of RAT. <b>Conclusion:</b> HT, anti-thrombocyte drug use, duration of compression, haematocrit levels and creatinine levels are identified as independent predictors of RAT. Standard pulse examination may not adequately detect RAT.</p>","PeriodicalId":12836,"journal":{"name":"Heart International","volume":"18 2","pages":"37-43"},"PeriodicalIF":1.9,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11781368/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143065149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erratum to Correct Errors in Text. 更正文本错误的勘误表。
IF 1.9 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-08-02 eCollection Date: 2024-01-01 DOI: 10.17925/HI.2024.18.2.6
Adam Ioannou

[This corrects the article DOI: 10.17925/HI.2024.18.1.5.].

[这更正了文章DOI: 10.17925/HI.2024.18.1.5.]。
{"title":"Erratum to Correct Errors in Text.","authors":"Adam Ioannou","doi":"10.17925/HI.2024.18.2.6","DOIUrl":"https://doi.org/10.17925/HI.2024.18.2.6","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.17925/HI.2024.18.1.5.].</p>","PeriodicalId":12836,"journal":{"name":"Heart International","volume":"18 2","pages":"3"},"PeriodicalIF":1.9,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11774339/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143065146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Heart International
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1